Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The blood-retinal barrier (BRB) is a critical physiological structure that maintains the specialized environment of the retina, essential for proper visual function. It acts as a selective barrier, regulating the movement of solutes, nutrients, and fluids between the bloodstream and retinal tissue while preventing potentially harmful substances from entering the retina. The BRB consists of two main components: the inner blood-retinal barrier (iBRB), formed by non-fenestrated endothelial cells lining retinal capillaries, and the outer blood-retinal barrier (oBRB), composed of retinal pigment epithelial (RPE) cells joined by tight junctions. Disruption or breakdown of either component leads to increased vascular permeability—an underlying factor in several sight-threatening diseases.
Therapeutic strategies often target pathways involved in barrier breakdown to restore integrity or modulate it for drug delivery purposes, e.g., by inhibiting VEGF.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Blood-Retinal Barrier (None).